OBJECTIVES: To determine levels of apolipoprotein (apo) A-I and apo H in the vitreous fluid of patients with proliferative diabetic retinopathy (PDR) and to examine whether apo A-I and apo H messenger RNA (mRNA) levels are overexpressed in the diabetic retina. METHODS: Vitreous samples from 4 diabetic patients with PDR and 8 nondiabetic patients with macular hole were selected for proteomic analysis. Fourteen additional samples (7 from patients with PDR and 7 from patients with macular hole) were used for Western blot analysis. Fourteen postmortem eyes (7 from diabetic and 7 from nondiabetic donors) were used to perform quantitative real-time polymerase chain reaction analysis. RESULTS: Intravitreous apo A-I and apo H levels were significantly higher in patients with PDR than in the control group. The apo A-I and apo H mRNA levels obtained from the retinas of diabetic donors were significantly higher than those obtained from nondiabetic donors. Retinal pigment epithelium was the main contributor to the differences. CONCLUSIONS: Levels of apo A-I and apo H are elevated in the vitreous fluid of diabetic patients with PDR. In addition, we provide the first evidence, to our knowledge, that a higher expression of apo A-I and apo H mRNAs exists in the diabetic retina. CLINICAL RELEVANCE: The results of this study may be relevant to new treatment strategies aimed toward reducing the development of diabetic retinopathy.
OBJECTIVES: To determine levels of apolipoprotein (apo) A-I and apo H in the vitreous fluid of patients with proliferative diabetic retinopathy (PDR) and to examine whether apo A-I and apo H messenger RNA (mRNA) levels are overexpressed in the diabetic retina. METHODS: Vitreous samples from 4 diabeticpatients with PDR and 8 nondiabetic patients with macular hole were selected for proteomic analysis. Fourteen additional samples (7 from patients with PDR and 7 from patients with macular hole) were used for Western blot analysis. Fourteen postmortem eyes (7 from diabetic and 7 from nondiabetic donors) were used to perform quantitative real-time polymerase chain reaction analysis. RESULTS: Intravitreous apo A-I and apo H levels were significantly higher in patients with PDR than in the control group. The apo A-I and apo H mRNA levels obtained from the retinas of diabetic donors were significantly higher than those obtained from nondiabetic donors. Retinal pigment epithelium was the main contributor to the differences. CONCLUSIONS: Levels of apo A-I and apo H are elevated in the vitreous fluid of diabeticpatients with PDR. In addition, we provide the first evidence, to our knowledge, that a higher expression of apo A-I and apo H mRNAs exists in the diabetic retina. CLINICAL RELEVANCE: The results of this study may be relevant to new treatment strategies aimed toward reducing the development of diabetic retinopathy.
Authors: Saloni Walia; Allen C Clermont; Ben-Bo Gao; Lloyd Paul Aiello; Edward P Feener Journal: Semin Ophthalmol Date: 2010 Sep-Nov Impact factor: 1.975
Authors: Jianzhong Chen; Dongfeng Cao; Seth D Fortmann; Christine A Curcio; Richard M Feist; Jason N Crosson Journal: Exp Eye Res Date: 2022-06-26 Impact factor: 3.770
Authors: Thomas F Dyrlund; Ebbe Toftgaard Poulsen; Carsten Scavenius; Camilla Lund Nikolajsen; Ida B Thøgersen; Henrik Vorum; Jan J Enghild Journal: J Proteome Res Date: 2012-07-10 Impact factor: 4.466
Authors: Martina Angi; Helen Kalirai; Sarah E Coupland; Bertil E Damato; Francesco Semeraro; Mario R Romano Journal: Mediators Inflamm Date: 2012-08-29 Impact factor: 4.711
Authors: Muhammad Bayu Sasongko; Tien Y Wong; Thanh T Nguyen; Ryo Kawasaki; Alicia Jenkins; Jonathan Shaw; Jie Jin Wang Journal: Diabetes Care Date: 2011-02 Impact factor: 19.112
Authors: Heather D VanGuilder; Georgina V Bixler; Lydia Kutzler; Robert M Brucklacher; Sarah K Bronson; Scot R Kimball; Willard M Freeman Journal: PLoS One Date: 2011-01-13 Impact factor: 3.240